EC Inventory

Nested Applications

EC Inventory

The EC inventory published below is a copy as received from the JRC in 2008 on the founding of ECHA. It is comprised of the following lists:

EINECS (European INventory of Existing Commercial chemical Substances) as published in O.J. C 146A, 15.6.1990. EINECS is an inventory of substances that were deemed to be on the European Community market between 1 January 1971 and 18 September 1981. EINECS was drawn up by the European Commission in the application of Article 13 of Directive 67/548/EEC, as amended by Directive 79/831/EEC, and in accordance with the detailed provisions of Commission Decision 81/437/EEC. Substances listed in EINECS are considered phase-in substances under the REACH Regulation.
ELINCS (European LIst of Notified Chemical Substances) in support of Directive 92/32/EEC, the 7th amendment to Directive 67/548/EEC. ELINCS lists those substances which were notified under Directive 67/548/EEC, the Dangerous Substances Directive Notification of New Substances (NONS) that became commercially available after 18 September 1981.
NLP (No-Longer Polymers). The definition of polymers was changed in April 1992 by Council Directive 92/32/EEC amending Directive 67/548/EEC, with the result that substances previously considered to be polymers were no longer excluded from regulation. Thus the No-longer Polymers (NLP) list was drawn up, consisting of such substances that were commercially available between 18 September 1981 and 31 October 1993.

Database contains 106212 unique substances/entries.

Filter the list

Showing 4,351 - 4,400 of 106,213 results.

Name	EC no.	CAS no.	Description	Molecular Formula
Pelargonium graveolens, ext., sapond.	305-057-8	94333-77-4			Details
Pelargonium graveolens, ext., borated	305-056-2	94333-76-3			Details
Hyacinth (plant), ext. Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Hyacinthus orientalis, Liliaceae.	305-055-7	94333-75-2	Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Hyacinthus orientalis, Liliaceae.		Details
Eugenia caryophyllata, ext., reaction products with formaldehyde	305-054-1	94333-73-0			Details
Cymbopogon winterianus, ext., reaction products with acetone	305-053-6	94333-72-9			Details
Cymbopogon winterianus, ext., hydrogenated	305-052-0	94333-71-8			Details
Cymbopogon winterianus, ext., acetylated	305-051-5	94333-70-7			Details
Cymbopogon nardus, ext., reaction products with acetone	305-049-4	94333-69-4			Details
Cymbopogon nardus, ext., hydrogenated	305-048-9	94333-68-3			Details
Cymbopogon nardus, ext., acetylated	305-047-3	94333-67-2			Details
(Z)-hex-3-enyl 2-(acetylamino)benzoate	305-046-8	94333-66-1		C15H19NO3	Details
Lauric acid, compound with diethylamine (1:1)	305-045-2	94333-65-0		C12H24O2.C4H11N	Details
Diethylammonium myristate	305-044-7	94333-64-9		C14H28O2.C4H11N	Details
Sodium 2-[(3-bromo-4-hydroxy-5-methylphenyl)(3-bromo-5-methyl-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]benzenesulphonate	305-043-1	94333-63-8		C21H16Br2O5S.Na	Details
DL-3-(3-thienyl)-β-alanine	305-042-6	94333-62-7		C7H9NO2S	Details
Potassium 2-benzoyl-6-naphthyl sulphate	305-041-0	94333-61-6		C17H12O5S.K	Details
1-[[5-(dimethylamino)-1-naphthyl]sulphonyl]-L-proline, compound with piperidine (1:1)	305-040-5	94333-60-5		C17H20N2O4S.C5H11N	Details
β-d-Fructofuranose, 1,6-bis(dihydrogen phosphate), tetrasodium salt	305-038-4	94333-59-2		C6H14O12P2.4Na	Details
β-d-Fructofuranose, 1,6-bis(dihydrogen phosphate), trisodium salt	305-037-9	94333-58-1		C6H14O12P2.3Na	Details
β-d-Fructofuranose, 6-(dihydrogen phosphate), disodium salt	305-036-3	94333-57-0		C6H13O9P.2Na	Details
5-fluoro-5,7,7-tris(trifluoromethyl)-6-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]-1,4-dioxepane	305-035-8	94333-56-9		C11H4F16O2	Details
Bis[2-(methacryloyloxy)ethyl] 5,7,7,24,24,26-hexamethyl-10,21-dioxo-11,14,17,20-tetraoxa-2,9,22,29-tetraazatriacontanedioate	305-034-2	94333-55-8		C40H70N4O14	Details
3-hydroxy-N-[2-(morpholino)ethyl]naphthalene-2-carboxamide hydrochloride	305-033-7	94333-54-7		C17H20N2O3.ClH	Details
1-[(7-bromo-3-hydroxy-2-naphthyl)carbonyl]-4-methylpiperazinium chloride	305-032-1	94333-53-6		C16H17BrN2O2.ClH	Details
N-[2-[(2-cyanoethyl)amino]ethyl]-N-[2-(stearoylamino)ethyl]stearamide	305-031-6	94333-52-5		C43H84N4O2	Details
Ethyl 6-ethylidene-2,2,5-trimethylcyclohexanecarboxylate	305-030-0	94333-51-4		C14H24O2	Details
Ethyl 2-ethyl-3,6,6-trimethylcyclohexenecarboxylate	305-029-5	94333-50-3		C14H24O2	Details
Bis[2-[ethyl[4-[(4-nitrophenyl)azo]phenyl]amino]ethyl] azelate	305-027-4	94333-49-0		C41H48N8O8	Details
Lithium hydrogen malate	305-026-9	94333-48-9		C4H6O5.Li	Details
Lithium hydrogen glutarate	305-025-3	94333-47-8		C5H8O4.Li	Details
Disodium 4-[3-(4,5-dichloro-2-methylphenyl)-4,5-dihydro-1-[4-[(2-hydroxyethyl)sulphonyl]phenyl]-1H-pyrazol-5-yl]benzene-1,3-disulphonate	305-024-8	94333-46-7		C24H22Cl2N2O9S3.2Na	Details
Lactic acid, compound with [2-(2-heptadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl]amine	305-023-2	94333-45-6		C22H45N3.xC3H6O3	Details
4,5-dihydro-2-heptadecyl-1H-imidazole-1-ethylamine acetate	305-022-7	94333-44-5		C22H45N3.xC2H4O2	Details
2-ethyl-N,N,3-trimethylvaleramide	305-021-1	94333-43-4		C10H21NO	Details
N,2-diethyl-3-methylvaleramide	305-020-6	94333-42-3		C10H21NO	Details
N-(2-hydroxy-1,1-dimethylethyl)-2-isobutyl-3-methylvaleramide	305-019-0	94333-41-2		C14H29NO2	Details
1-[2,4-dimethyl-2-(isobutyl)-1-oxopentyl]pyrrolidine	305-018-5	94333-40-1		C15H29NO	Details
Tin 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate (1:2)	305-016-4	94333-39-8		C5H4N2O4.1/2Sn	Details
Manganese 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate (1:2)	305-015-9	94333-38-7		C5H4N2O4.1/2Mn	Details
Cobalt 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate (1:2)	305-014-3	94333-37-6		C5H4N2O4.1/2Co	Details
Iron 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate (1:2)	305-013-8	94333-36-5		C5H4N2O4.1/2Fe	Details
Chromium 1,2,3,6-tetrahydro-2,6-dioxopyrimidine-4-carboxylate (1:3)	305-012-2	94333-35-4		C5H4N2O4.1/3Cr	Details
Octyl L-cysteinate hydrochloride	305-011-7	94333-34-3		C11H23NO2S.ClH	Details
2-[2-hydroxy-3-(trimethylammonio)propoxy]-3-[1-[(tridecyloxy)methyl]-2-(trimethylammonio)ethoxy]propyltrimethylammonium trichloride	305-010-1	94333-33-2		C31H70N3O4.3Cl	Details
Bis[2,3-bis(palmitoyloxy)propyl] 6,12,17,23,28,34,39,45,50,56-decaoxo-9,20,31,42,53-pentakis(palmitoyloxy)-7,11,18,22,29,33,40,44,51,55-decaoxahenhexacontanedioate	305-009-6	94333-32-1		C201H362O42	Details
Di[(Z)-octadec-9-enyl] hydrogen dithiophosphate, compound with 2-aminoethanol (1:1)	305-008-0	94333-31-0		C36H71O2PS2.C2H7NO	Details
N-butylphosphorothioic triamide	435-740-7	94317-64-3	NBPT		Details
Dipotassium [4-[4,5-dihydro-4-[[2-hydroxy-5-[[2-(sulphooxy)ethyl]sulphonyl]phenyl]azo]-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonato(4-)]cuprate(2-)	305-007-5	94314-07-5		C18H14CuN4O11S3.2K	Details
Bis[2-(4-chloro-o-tolyloxy)propionato-O1,O2]magnesium	305-005-4	94314-06-4		C20H20Cl2MgO6	Details
Dihydrogen heptaoxotetraborate(2-), compound with cyclohexylamine (1:2)	305-004-9	94314-05-3		C6H13N.1/2B4O7.H	Details

Showing 4,351 - 4,400 of 106,213 results.

Export search results to:

EC Inventory

EC Inventory

Nested Applications

EC Inventory

See a problem or have feedback?

Database contains 106212 unique substances/entries.

Footer Nav Items